HOST-SPECIFIC INTERLEUKIN-2-SECRETING DONOR T-CELL PRECURSORS AS PREDICTORS OF ACUTE GRAFT-VERSUS-HOST DISEASE IN BONE-MARROW TRANSPLANTATION BETWEEN HLA-IDENTICAL SIBLINGS

被引:161
作者
THEOBALD, M [1 ]
NIERLE, T [1 ]
BUNJES, D [1 ]
ARNOLD, R [1 ]
HEIMPEL, H [1 ]
机构
[1] UNIV HOSP ULM, DEPT INTERNAL MED 3, BONE MARROW TRANSPLANTAT UNIT, ULM, GERMANY
关键词
D O I
10.1056/NEJM199212033272301
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Acute graft-versus-host disease (GVHD) is a serious complication of allogeneic bone marrow transplantation from an HLA-identical sibling. There is no practical test before transplantation that gives sufficient information to predict the degree of allogeneic reactivity between HLA-identical siblings. Methods. We determined the frequency with which host-specific interleukin-2-secreting donor T-cell precursors occurred in 16 consecutive pairs of HLA-identical siblings before they underwent marrow grafting. The results were correlated with the development of acute GVHD after transplantation. Results. High frequencies of host-specific T-cell precursors (greater-than-or-equal-to 1 per 100,000) were detectable before transplantation in eight donors whose siblings later had severe (grade II or III) acute GVHD. Among the donors to eight patients with mild (grade 0 or I) acute GVHD, low frequencies (<1 per 100,000) were found. Conclusions. Analysis of the frequency of such cells before transplantation may be a useful predictor of severe acute GVHD in allogeneic bone marrow transplantation between HLA-identical siblings. It is possible that the patients at risk for serious acute GVHD after marrow grafting may benefit from some alternative form of immunosuppressive therapy.
引用
收藏
页码:1613 / 1617
页数:5
相关论文
共 33 条
[1]  
ALDACCAK R, 1990, LEUKEMIA, V4, P222
[2]  
CHAMPLIN R, 1990, BLOOD, V76, P418
[3]  
CLEVELAND MG, 1988, J IMMUNOL, V141, P3349
[4]   MINOR HISTOCOMPATIBILITY ANTIGENS, DEFINED BY GRAFT-VS-HOST DISEASE-DERIVED CYTOTOXIC LYMPHOCYTES-T, SHOW VARIABLE EXPRESSION ON HUMAN SKIN CELLS [J].
DEBUEGER, M ;
BAKKER, A ;
VANROOD, JJ ;
GOULMY, E .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1991, 21 (11) :2839-2844
[5]  
DELMONTE L, 1982, TRANSPLANTATION, V34, P100
[6]  
EIERMANN TH, 1991, TISSUE ANTIGENS, V38, P193
[7]  
FERRARA JLM, 1991, NEW ENGL J MED, V324, P667
[8]   CLINICAL MANIFESTATIONS OF GRAFT VERSUS HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONORS [J].
GLUCKSBERG, H ;
STORB, R ;
FEFER, A ;
BUCKNER, CD ;
NEIMAN, PE ;
CLIFT, RA ;
LERNER, KG ;
THOMAS, ED .
TRANSPLANTATION, 1974, 18 (04) :295-304
[9]  
GOULMY E, 1988, TRANSPLANT REV, V2, P29, DOI DOI 10.1016/S0955-470X(88)80005-3
[10]  
HAMILTON BL, 1987, J IMMUNOL, V139, P2511